Author

T. A. Yuniarta

h-index 3 View on Semantic Scholar

We have 3 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Nipah virus vaccine development: current platforms, preclinical evidence, and clinical translation

Nipah virus (NiV) is a highly pathogenic zoonotic member of the genus Henipavirus . Due to its high fatality rate and increasing evidence of human-to-human transmission, it remains a major global health concern. Since its first emergence during the Malaysian outbreak, NiV has caused repeated outbreaks across South...

S. Chatterjee, Joydeep Mahata, Athika Firdous et al. · Frontiers in Drug Discovery · 1 citation

Open access Aug 2026

Computational Predicted Mechanism of Tiliroside Compound Against Triple-Negative Breast Cancer Using Network Pharmacology and Induced-Fit Docking Approach

BACKGROUND: Triple-negative breast cancer (TNBC) progression is driven by dysregulation of multiple interconnected signaling pathways rather than a single molecular abnormality, but current treatment strategies TNBC primarily rely on single-target therapy, highlighting the need for therapeutic candidates that may targe...

T. A. Yuniarta, D. S. F. Ramadhan, Zulfikar Ali Hasan et al. · Indonesian Biomedical Journa... · 0 citations

Open access Jul 2026

Molegro Virtual Docker-Based Prediction of Rhodomyrtus tomentosa Metabolites Targeting Ribonucleotide Reductase as Potential Anticancer Agents

R. tomentosa B has potential as a natural product-based anticancer agent targeting RNR, providing a basis for further in vitro and in vivo studies and ADMET analysis indicated variability in pharmacokinetic properties.

Imam Nurjaman, D. Kesuma, T. A. Yuniarta et al. · Indonesian Journal of Cancer... · 0 citations